cancer

At UCLA, Dr. David Nathanson is designing new therapies that tackle glioblastoma’s unique tumor biology, aiming to overcome long-standing treatment challenges.

The test could offer a more affordable approach to early disease detection.

The advance could lead to safer, more effective T cell therapies for prostate cancer and other solid tumors.

CAR-NKT cell therapy can be produced at a fraction of the cost of personalized treatments.

By equipping T cells with two proteins derived from fungi, the researchers enabled the immune cells to import cellobiose and convert it into usable glucose inside the cell.

The UCLA Research Park is two years away from opening its doors. But it’s already buzzing with energy and ideas.

The research team engineered human blood stem cells to produce specialized immune cells called NKT cells.

The gift will support the UCLA-Caltech Medical Scientist Training Program by funding an endowed chair and a fellowship.

The study is the first large-scale clinical trial to show that a new oral endocrine therapy outperforms the long-standing standard therapies used for early-stage HR-positive/HER2-negative breast cancer.

Simms/Mann dietitian Deborah Hong discusses the link between excessive sugar and cancer risk.

Bruingenuity is on vivid display in myriad inventions that save and improve lives every day. Bonus: gourmet slime!

As a child, Tae-León Butler received lifesaving cancer treatment at UCLA. Now, she’s back on campus to become a pediatric oncology physician herself.

With 285 new inventions last year alone, UCLA’s research and creative activities are powering progress far beyond campus.

Listen to Knaul, associate of the UCLA chancellor and a distinguished professor of medicine, on UCLA Health’s “Medically Speaking” podcast.

Following the team’s discovery, researchers have identified a strategy to possibly prevent treatment relapses.

The findings mark the first time this regimen has demonstrated a survival benefit in the vast majority of patients with metastatic colorectal cancer.

The same cell therapy could potentially be used to treat multiple solid tumors like ovarian, pancreatic and lung cancers.

10 pediatric oncology patients at UCLA Health who were guests of Major League Baseball’s Childhood Cancer Awareness Night.

The off-the-shelf treatment also had an impact on preventing or delaying cancer recurrence in high-risk patients.

Linguistics professor Jessica Rett is studying how different words related to ‘cancer’ can influence patients’ treatment decisions.

Chancellor Frenk shared a message with the UCLA community providing an update on research grant suspensions and highlighting stories that illustrate UCLA’s impact.

Stereotactic body radiation therapy offers a noninvasive option for treating early-stage EGFR-positive lung cancer.

Here are just some of the lifesaving therapies that were developed by or stemmed from research at UCLA.

The study found pembrolizumab shrank or eliminated tumors in nearly 90% of participants with desmoplastic melanoma that cannot be surgically removed.

The team will now seek FDA approval to open a clinical trial for the CAR-NKT cell therapy.